Skip to main content
Signal8

Hall Brett Matthew

SEC insider (Form 3/4/5 filer). CIK 0001870437. CHIEF SCIENTIFIC OFFICER at Immuneering Corp (IMRX). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in CAMBRIDGE, MA.

Companies Hall Brett Matthew has filed insider reports for

  • Immuneering Corp (IMRX): Officer, CHIEF SCIENTIFIC OFFICER
Hall Brett Matthew profile photo

Hall Brett Matthew

CIK: 0001870437

Transaction Breakdown

Open Market Buys (P)4 (57.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immuneering Corp logo
IMRX

Immuneering Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 15, 2026
    Purchase
    Direct
    6K shares at avg. $4.15$25K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Feb 3, 2026
    Award

    Stock Option

    Direct
    344K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jan 15, 2026
    Purchase
    Direct
    2.3K shares at avg. $4.57$11K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Sep 15, 2025
    Award
    Direct
    14.9K shares at avg. $1.43$21K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 23, 2025
    Purchase
    Direct
    6K shares at avg. $2.43$15K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 20, 2025
    Purchase
    Direct
    7.4K shares at avg. $2.70$20K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Feb 5, 2025
    Award

    Stock Option

    Direct
    240K shares-

1-7 of 7